ArticleOncotarget2018

Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events.

Tatsuo Kanda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.